Regeneron Pharmaceut

REGN
Real-time BATS EXCHANGE - 11/20 04:00:00 pm
344.145USD
-0.07%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:
- sales of products (61.2%);
- supply of collaborative services (32.6%): working with Sanofi (50.8% of sales) and Bayer (49.2%);
- sales of technology licenses (6.2%). The group also provides subcontracting research services.
At the end of 2018, the group had a portfolio of 21 products in clinical development.

Number of employees : 7 400 people.
Sales per Businesses
20172018
USD
(in Million)
%USD
(in Million)
%
Eylea 3,70263% 4,07760.7%
Bayer Collaboration 938.1016% 1,07716%
Sanofi Collaboration 877.2014.9% 1,11116.6%
Other 338.505.8% 416.806.2%
Arcalyst 16.500.3% 14.700.2%
Libtayo -- 14.800.2%
Sales per Regions
20172018
USD
(in Million)
%USD
(in Million)
%
United States, European Union, Japan 5,872100% 6,711100%
Managers
Name Title
Leonard S. Schleifer Co-President, Chief Executive Officer & Director
George Damis Yancopoulos Co-President, Director & Chief Scientific Officer
P. Roy Vagelos Chairman
Robert E. Landry Chief Financial Officer & Executive VP-Finance
Michael S. Brown Independent Director
Joseph L. Goldstein Independent Director
George L. Sing Independent Director
Arthur Frederick Ryan Independent Director
Christine A. Poon Independent Director
Marc Tessier-Lavigne Independent Director
Shareholders
Name Equities %
Sanofi 23,350,365 21.6%
Capital Research & Management Co. (World Investors) 8,206,647 7.60%
The Vanguard Group, Inc. 6,091,269 5.64%
Harris Associates LP 4,141,452 3.84%
Capital Research & Management Co. (Global Investors) 3,821,000 3.54%
Loomis, Sayles & Co. LP 3,591,797 3.33%
SSgA Funds Management, Inc. 3,529,859 3.27%
Fidelity Management & Research Co. 2,657,044 2.46%
Icahn Associates Holding LLC 2,444,081 2.26%
The Procter & Gamble Company 2,214,855 2.05%
Company contact information
777 Road Old Saw Mill River
NY 10591 Tarrytown, New York
États-Unis (les)

Phone : +1 (914) 847 7000
Fax : +1
Internet : http://www.regeneron.com
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 500
Stock Exchange Codes
- Reuters Code :  REGN.O
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
REGENERON PHARMACEUTICALS-7.78%37 657
GILEAD SCIENCES3.92%82 234
VERTEX PHARMACEUTICALS29.74%55 287
WUXI APPTEC CO., LTD.84.77%22 783
GENMAB41.31%14 557
BEIGENE, LTD.45.37%12 362
NEUROCRINE BIOSCIENCES, INC.60.54%10 382
AMARIN CORPORATION PLC67.01%8 158
HUALAN BIOLOGICAL ENGINEERING INC--.--%7 538
SAREPTA THERAPEUTICS, INC.-10.16%7 308
REATA PHARMACEUTICALS, INC.267.20%6 730
ARGENX SE51.17%6 097
PEPTIDREAM INC.18.87%5 814
ASCENDIS PHARMA A/S81.10%5 417
EXELIXIS, INC.-15.96%5 023
ARROWHEAD PHARMACEUTICALS, INC.306.60%4 813
CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.53.72%4 486
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.8.27%4 356
SPARK THERAPEUTICS, INC.184.44%4 289
BIOCON LIMITED-17.80%4 255
BLUEBIRD BIO, INC.-25.40%4 094